Variables
|
All patients (n = 77)
|
Propensity score matched patients (50 pairs)
|
---|
Normalized group
|
Non-normalized group
|
P
|
Normalized group
|
Non-normalized group
|
p
|
---|
(n = 37)
|
(n = 40)
|
(n = 25)
|
(n = 25)
|
---|
No. of patients (%)
|
No. of patients (%)
|
No. of patients (%)
|
No. of patients (%)
|
---|
Age (years)
| | |
0.279
| | |
0.929
|
Median
|
62
|
59
| |
58
|
60
| |
Range
|
47–78
|
39–78
| |
50–69
|
39–78
| |
Gender
| | |
0.550
| | |
0.747
|
Male
|
29 (78.4)
|
29 (72.5)
| |
19 (76.0)
|
18 (72.0)
| |
Female
|
8 (21.6)
|
11 (27.5)
| |
6 (24.0)
|
7 (28.0)
| |
ECOG PS
| | |
0.197
| | |
0.156
|
0
|
23 (62.2)
|
19 (47.5)
| |
16 (64.0)
|
11 (44.0)
| |
1–2
|
14 (37.8)
|
21 (52.5)
| |
9 (36.0)
|
14 (56.0)
| |
Child-Pugh classification
| | |
0.945
| | |
0.480
|
A
|
28 (75.7)
|
30 (75.0)
| |
19 (76.0)
|
21 (84.0)
| |
B
|
9 (24.3)
|
10 (25.0)
| |
6 (24.0)
|
4 (16.0)
| |
Viral etiology
| | |
0.402
| | |
1.000
|
HBs-Ag (+)
|
29 (78.4)
|
28 (70.0)
| |
20 (80.0)
|
20 (80.0)
| |
HBs-Ag (−)
|
8 (21.6)
|
12 (30.0)
| |
5 (20.0)
|
5 (20.0)
| |
Tumor size (cm)
| | |
0.488
| | |
0.344
|
Median
|
2.0
|
1.7
| |
2.1
|
1.6
| |
Range
|
0.8–4.5
|
1.0–4.4
| |
1.0–4.5
|
1.2–3.6
| |
Initial AFP (ng/mL)
| | |
0.187
| | |
0.655
|
Median
|
48.6
|
128.0
| |
50.2
|
113.0
| |
Range
|
20.8–1870.0
|
20.3–3250.0
| |
21.2–1870.0
|
20.3–2490.0
| |
ALT
| | |
0.093
| | |
0.981
|
Median
|
25
|
28.5
| |
27
|
25
| |
Range
|
9–55
|
11–185
| |
9–55
|
14–116
| |
Albumin
| | |
0.383
| | |
0.395
|
Median
|
3.6
|
3.4
| |
3.4
|
3.6
| |
Range
|
2.4–4.5
|
2.4–4.7
| |
2.4–4.5
|
2.9–4.7
| |
Bilirubin
| | |
0.841
| | |
0.804
|
Median
|
1.1
|
1.1
| |
1.0
|
1.0
| |
Range
|
0.5–3.5
|
0.6–6.2
| |
0.5–2.9
|
0.6–6.2
| |
INR
| | |
0.550
| | |
0.514
|
Median
|
1.1
|
1.1
| |
1.2
|
1.1
| |
Range
|
0.9–1.5
|
0.9–1.7
| |
0.9–1.5
|
0.9–1.7
| |
Radiation dose
| | |
0.909
| | |
0.743
|
Median
|
45
|
45
| |
45
|
45
| |
Range
|
36–60
|
36–60
| |
36–60
|
36–60
| |
- Abbreviations: ECOG PS Eastern Cooperative Oncology Group performance status, HBs-Ag hepatitis B surface-antigen, AFP alpha-fetoprotein, ALT alanine aminotransferase, INR international normalized ratio